Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josefine Radke

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Children (Basel, Switzerland)|July 2, 2021
Germline Mutations Including the Rare Pathogenic Variant c.3206delC in the <i>ATM</i> Gene Cause Ataxia Teleangiectasia-Associated Primary Central Nervous System LymphomaJan R Dörr, Anne Thorwarth, Agnieszka Mizia-Malarz, et al.
Molecular Cancer Research : MCR|February 3, 2017
Prognostic Relevance of Tumor Purity and Interaction with MGMT Methylation in GlioblastomaEva Schulze Heuling, Felix Knab, Josefine Radke, et al.
Neuropathology and Applied Neurobiology|May 10, 2021
Successful plasmapheresis and immunoglobulin treatment for severe lipid storage myopathy: Doing the right thing for the wrong reasonFelix Kleefeld, Anja von Renesse, Carsten Dittmayer, et al.
Acta Neuropathologica Communications|June 7, 2019
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patientsJosefine Radke, Arend Koch, Fabienne Pritsch, et al.
Brain Pathology (Zurich, Switzerland)|May 27, 2021
NanoString technology distinguishes anti-TIF-1γ<sup>+</sup> from anti-Mi-2<sup>+</sup> dermatomyositis patientsCorinna Preusse, Pascale Eede, Lucie Heinzeling, et al.
Frontiers in Oncology|May 27, 2021
Optical Characterization of Sodium Fluorescein <i>In Vitro</i> and <i>Ex Vivo</i>Ran Xu, Wanda Teich, Florian Frenzel, et al.
Acta Neuropathologica|February 22, 2024
MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
Acta Neuropathologica|March 27, 2024
Correction to: MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
Free Neuropathology|January 11, 2024
Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositisVictor M Corman, Corinna Preusse, Julia Melchert, et al.
Experimental Hematology & Oncology|February 20, 2026
Molecular background of Philadelphia chromosome dependent enhancement of cellular growth and tyrosine kinase inhibitor sensitivityMd Faruq Hossain, Lisa Hagenau, Lars R Jensen, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Children (Basel, Switzerland)|July 2, 2021
Germline Mutations Including the Rare Pathogenic Variant c.3206delC in the <i>ATM</i> Gene Cause Ataxia Teleangiectasia-Associated Primary Central Nervous System LymphomaJan R Dörr, Anne Thorwarth, Agnieszka Mizia-Malarz, et al.
Molecular Cancer Research : MCR|February 3, 2017
Prognostic Relevance of Tumor Purity and Interaction with MGMT Methylation in GlioblastomaEva Schulze Heuling, Felix Knab, Josefine Radke, et al.
Neuropathology and Applied Neurobiology|May 10, 2021
Successful plasmapheresis and immunoglobulin treatment for severe lipid storage myopathy: Doing the right thing for the wrong reasonFelix Kleefeld, Anja von Renesse, Carsten Dittmayer, et al.
Acta Neuropathologica Communications|June 7, 2019
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patientsJosefine Radke, Arend Koch, Fabienne Pritsch, et al.
Brain Pathology (Zurich, Switzerland)|May 27, 2021
NanoString technology distinguishes anti-TIF-1γ<sup>+</sup> from anti-Mi-2<sup>+</sup> dermatomyositis patientsCorinna Preusse, Pascale Eede, Lucie Heinzeling, et al.
Frontiers in Oncology|May 27, 2021
Optical Characterization of Sodium Fluorescein <i>In Vitro</i> and <i>Ex Vivo</i>Ran Xu, Wanda Teich, Florian Frenzel, et al.
Acta Neuropathologica|February 22, 2024
MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
Acta Neuropathologica|March 27, 2024
Correction to: MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
Free Neuropathology|January 11, 2024
Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositisVictor M Corman, Corinna Preusse, Julia Melchert, et al.
Experimental Hematology & Oncology|February 20, 2026
Molecular background of Philadelphia chromosome dependent enhancement of cellular growth and tyrosine kinase inhibitor sensitivityMd Faruq Hossain, Lisa Hagenau, Lars R Jensen, et al.
Pageof 6